Iterum Therapeutics plc (OTCPK: ITRM.F)
Health Care · Pharmaceuticals · IE
$0.00
-90.00% today · -100.0% 1Y
Iterum Therapeutics plc (OTCPK: ITRM.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $53.00 and employs 9 people.
Over the last twelve months the share price has lost 100.0%, trading between 0.00 and 0.83.
Tweenvest scores Iterum Therapeutics plc across four factors: quality 11/100, value 60/100. Its strongest factor is value.
ITRM.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $53.00
- Revenue (TTM)
- $390.00K
- P/E
- —
- EPS
- -0.74
- Dividend yield
- —
- Beta (5Y)
- 3.92
- 52-week high
- $0.83
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 52.84M
- Employees
- 9
- Next earnings
- —
About Iterum Therapeutics plc
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
- ISIN
- IE000TTOOBX0
- Founded
- 2015
- Listed since
- May 25, 2018
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.80 | +0.11% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.